SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
TB: FROM CONTACT TO CURE AND BEYOND
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
8 of
8
|
IPT AND PREGNANCY OUTCOMES IN HIV-POSITIVE WOMEN: THE TSHEPISO COHORT (ABSTRACT
77)
Nicole Salazar-Austin
Johns Hopkins University School of Medicine, Baltimore, MD, USA
POTENTIAL CONCERN FOR TIMING OF DMPA INJECTION AMONG WOMEN TREATED FOR HIV AND TB (ABSTRACT
78)
Rosie Mngqibisa
Enhancing Care Initiative, Durban RSA, South Africa
IMPROVING CHILD TUBERCULOSIS CONTACT MANAGEMENT IN LESOTHO (ABSTRACT
79)
Yael Hirsch-Moverman
Columbia University, Mailman School of Public Health, New York, NY, USA
SAFETY & PK OF WEEKLY RIFAPENTINE/ISONIAZID (3HP) IN ADULTS WITH HIV ON DOLUTEGRAVIR (ABSTRACT
80)
Kelly E Dooley
Johns Hopkins University, Baltimore, MD, USA
PHARMACOKINETICS AND SAFETY OF ADJUSTED DARUNAVIR/RITONAVIR WITH RIFAMPIN IN PLWH (ABSTRACT
81)
Gary Maartens
University of Cape Town, Cape Town, South Africa
EARLY BACTERICIDAL ACTIVITY OF HIGH-DOSE ISONIAZID AGAINST MULTIDRUG-RESISTANT TB (ABSTRACT
82)
Kelly E Dooley
Johns Hopkins University, Baltimore, MD, USA
LONG-TERM MORTALITY AFTER TUBERCULOSIS CURE IN THE CIPRA HT-001 TRIAL (ABSTRACT
83)
Yvetot Joseph
Les Centres GHESKIO, Haiti, Port-au-Prince, Haiti
QT EFFECTS OF BEDAQUILINE, DELAMANID OR BOTH IN MDR-TB PATIENTS: THE DELIBERATE TRIAL (ABSTRACT
84)
Gary Maartens
University of Cape Town, Cape Town, South Africa
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
8 of
8
|
